DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Transcatheter Mitral Valve Replacement Market 2016-2020" report to their offering.
The global transcatheter mitral valve replacement market to grow at a CAGR of 21.93% during the period 2016-2020.
The report covers the present scenario and the growth prospects of the global transcatheter mitral valve replacement market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of transcatheter mitral valve implants. The report also includes a discussion of the key vendors operating in this market.
According to the report, prevalence of mitral regurgitation is one of the drivers that led to the growth of this market. Mitral regurgitation is a common heart valve disorder that affects 2%-3% of the population worldwide. The disorder is becoming prevalent among all age groups rapidly. About 0.5% of individuals aged 18-45 and 9% of people aged 60-75 have this disorder. In 2009, research studies estimated that more than 176 million people worldwide have the disorder. These studies also estimated that more than four million individuals in the US had mitral regurgitation. Of this number, about one in 10 individuals was aged 75 and above.
Further, the report states that availability of alternative treatment is negatively affecting the sales of transcatheter mitral valve implants. Transcatheter mitral valve replacement is a minimally invasive surgical procedure. This procedure has been proven to be safe and efficient, improving the quality of life. However, mitral valve repair surgical procedures are medical consultants' first choice for treating mitral regurgitation.
Mitral valve repair surgery involves the implantation of a stent-like device for reshaping the posterior region of the annulus to repair the damaged mitral valve. The surgical procedure offers better postoperative left ventricular function, lowers long-term morbidity, and increases life expectancy compared to transcatheter mitral valve replacement procedure. Cardiac Dimensions' Carillon and Edwards Lifesciences' Monarc are two major mitral valve repair devices available in the market. These devices are less expensive compared to transcatheter mitral valve replacement devices.
- Abbott Laboratories
- Edwards Lifesciences
- Micro Interventional Devices
Other prominent vendors
- NaviGate Cardiac Structures
- Boston Scientific
For more information visit http://www.researchandmarkets.com/research/zngs9s/global